TRUE Private Wealth Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-135
Closed -$33K 283
2020
Q4
$33K Hold
135
0.01% 395
2020
Q3
$38K Buy
135
+35
+35% +$9.76K 0.01% 353
2020
Q2
$26K Hold
100
﹤0.01% 390
2020
Q1
$31K Sell
100
-1,147
-92% -$348K 0.01% 336
2019
Q4
$370K Buy
1,247
+100
+9% +$27.7K 0.06% 155
2019
Q3
$267K Hold
1,147
0.05% 171
2019
Q2
$268K Buy
1,147
+22
+2% +$5.08K 0.05% 167
2019
Q1
$265K Sell
1,125
-29
-3% -$9.13K 0.05% 170
2018
Q4
$347K Hold
1,154
0.06% 170
2018
Q3
$408K Buy
1,154
+3
+0.3% +$1.03K 0.06% 190
2018
Q2
$334K Sell
1,151
-27
-2% -$7.59K 0.05% 198
2018
Q1
$322K Hold
1,178
0.06% 176
2017
Q4
$375K Buy
1,178
+43
+4% +$13.8K 0.07% 160
2017
Q3
$355K Hold
1,135
0.08% 106
2017
Q2
$307K Hold
1,135
0.07% 112
2017
Q1
$305K Hold
1,135
0.07% 108
2016
Q4
$319K Hold
1,135
0.08% 105
2016
Q3
$334K Hold
1,135
0.11% 91
2016
Q2
$274K Hold
1,135
0.09% 106
2016
Q1
$295K Buy
+1,135
New +$300K 0.11% 89

Other funds holding BIIB

TRUE Private Wealth Advisors's BIIB Position: Q1 2021 in Review

TRUE Private Wealth Advisors sold out of Biogen (BIIB) in Q1 2021, closing a stake of 135 shares — an estimated $33K sold.

TRUE Private Wealth Advisors first reported a position in BIIB in Q1 2016 and held it in 20 quarters. The position peaked at $408K in Q3 2018. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • TRUE Private Wealth Advisors reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
  • TRUE Private Wealth Advisors sold 135 Biogen shares in Q1 2021, an estimated $33K.
  • TRUE Private Wealth Advisors first reported a position in Biogen in Q1 2016 and held it in 20 quarters.
  • TRUE Private Wealth Advisors's Biogen position peaked at $408K in Q3 2018.
  • 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on TRUE Private Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.